Current Month 2011
Article Features
  A New Molecular Mechanism in Breast Cancer Development
Advances in Breast Cancer Donít Extend to Older Women
Benefit of Novel Breast Cancer Drug Seen in Blood Within Weeks
Canadian Task Force Guidelines for Breast Cancer Screening Would Cost Thousands of Lives Each Year
Cancer Vaccine Impact Will Be Limited Unless Drug Industry Focuses on Difficult-to-Treat Tumors
Diabetes Drug Shows Promise in Reducing Risk of Cancer
Employers Need to Tackle Culture of Ignorance Around Breast Cancer Survivors Who Work
HDAC Inhibitor May Overcome Resistance to Common Breast Cancer Drug
High Levels of Master Heat Shock Protein Linked to Poor Prognosis in Breast Cancer Patients
High Tech Detection of Breast Cancer Using Nanoprobes and SQUID
Low Levels of Alcohol Consumption Associated with Small Increased Risk of Breast Cancer
Neurological and Executive Function Impairment Associated with Breast Cancer
No Higher Risk of Breast Cancer for Women Who Donít Have BRCA Mutation But Have Relatives Who Do
PBX1 Identified as a New Pioneer Factor Underlying Progression in Breast Cancer
Protein Found to be Critical in Breast Cancer Spread
Rates of Breast Reconstruction After Mastectomy in Canada
Researchers Discover Key Aspect of Process That Activates Breast Cancer Genes
Researchers Find Genetic Rearrangements Driving 5 to 7 Percent of Breast Cancers
Researchers Find Way to Screen for Broad Range of Cancer-Causing Genetic Changes
Researchers Train Computer to Evaluate Breast Cancer
Signaling Pathway Linked to Inflammatory Breast Cancer May Drive Disease Metastasis
Studies Link Depression and Breast Cancer Outcomes
Study Helps Eliminate Causes for Joint Pain Linked to Commonly Used Breast Cancer Drugs
Tamoxifen Causes Significant Side Effects in Male Breast Cancer Patients
Vaccine for Metastatic Breast, Ovarian Cancer Shows Promise


Diabetes Drug Shows Promise in Reducing Risk of Cancer

An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher.

The research, led by pediatrics professor James Trosko and colleagues from South Korea's Seoul National University, provides biological evidence for previously reported epidemiological surveys that long-term use of the drug metformin for Type-2 diabetes reduces the risk of diabetes-associated cancers, such as breast cancers.

The research appears in the journal PLoS One.

"People with Type-2 diabetes are known to be at high risk for several diabetes-associated cancers, such as breast, liver and pancreatic cancers," said Trosko, a professor in the College of Human Medicine's Department of Pediatrics and Human Development. "While metformin has been shown in population studies to reduce the risk of these cancers, there was no evidence of how it worked."

Read More of the Main Article

 
Visit the Ezine


Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon